Myriad Genetics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2022
Total Assets: $1.20B
Liabilities Breakdown FY2022
Total Liabilities: $312.9M
Asset Breakdown
Total Assets: $1.20B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $56.9M | 4.7% |
| Accounts Receivable | $101.6M | 8.5% |
| Inventory | $20.1M | 1.7% |
| Property, Plant & Equipment | $83.4M | 7.0% |
| Goodwill | $286.8M | 23.9% |
| Intangible Assets | $379.7M | 31.7% |
| Other Assets | $270.2M | 22.5% |
Liabilities Breakdown
Total Liabilities: $312.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $28.8M | 9.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $284.1M | 90.8% |